Roche's Webcast Replay on Gazyva in lupus nephritis presented at ASN/ACR 2019
Roche has hosted a live audio webcast and conference call on Tuesday, 12 November 2019.
Karl Mahler, Head of Investor Relations
- Roche in immunology – overview
Mark Eisner, Global Head of Product Development – Immunology, Infectious Disease & Ophthalmology
- Phase II Nobility data - efficacy and safety of obinutuzumab or placebo in combination with mycophenolate mofetil in patients with Lupus Nephritis
Larry Tsai, Global Head of Rheumatology & Respiratory Development
Please register to access the webcast